Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Jade Biosciences, Inc.’s names, not what it holds today.
Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 2 in 2023
Applications published
16
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Aerovate Therapeutics, Inc. a former name
named as the applicant on its applications, in US
15 publishedAerovate Therapeutics, Inc. a former name
US, as the owner printed on each patent
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 14, 2023 | 11,813,263 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Nov 7, 2023 | 11,806,349 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Oct 11, 2022 | 11,464,776 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Aug 16, 2022 | 11,413,289 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Apr 12, 2022 | 11,298,355 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Jan 25, 2022 | 11,229,650 | Inhalable imatinib formulations, manufacture, and uses thereof | Pharmaceuticals | Aerovate Therapeutics, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 3, 2024 | 2024/0325390 | IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Apr 25, 2024 | 2024/0130966 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Apr 4, 2024 | 2024/0108622 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Feb 8, 2024 | 2024/0041879 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Mar 23, 2023 | 2023/0086230 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. · patent 11,813,263 granted from it |
| Feb 23, 2023 | 2023/0056721 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Jul 14, 2022 | 2022/0218706 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. · patent 11,806,349 granted from it |
| Jun 16, 2022 | 2022/0184080 | NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. |
| Dec 3, 2020 | 2020/0375895 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Pharmaceuticals | Aerovate Therapeutics, Inc. · patent 11,464,776 granted from it |
| Nov 19, 2020 | 2020/0360477 | INHALABLE FORMULATIONS FOR KINASE INHIBITION | Pharmaceuticals | Aerovate Therapeutics, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 4.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.